Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
<p>Tuberculosis poses a serious global health threat, with an estimated 9 million new cases and 1.5 million deaths annually. The current vaccine, BCG, is inadequate but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. Candidate vacc...
第一著者: | Tanner, R |
---|---|
その他の著者: | McShane, H |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2015
|
主題: |
類似資料
-
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
著者:: Pepponi, I, 等
出版事項: (2017) -
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
著者:: Rachel Tanner, 等
出版事項: (2020-01-01) -
In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
著者:: Hyejon Lee, 等
出版事項: (2019-04-01) -
Mycobacterial glycoproteins: a novel subset of vaccine candidates
著者:: Antonio eFacciuolo, 等
出版事項: (2014-09-01) -
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
著者:: Tanner, R, 等
出版事項: (2021)